Acute myeloblastic leukemia without maturation
MONDO:0005224An acute myeloid leukemia (AML) characterized by blasts without evidence of maturation to more mature neutrophils. (WHO, 2001)
Also known as: AML M1, AML without maturation, FAB M1, M1 acute granulocytic leukaemia, M1 acute granulocytic leukaemia without maturation, M1 acute granulocytic leukemia, M1 acute granulocytic leukemia without maturation, M1 acute myeloblastic leukaemia
3082 clinical trials for this condition and its sub-types, 4 tagged with Acute myeloblastic leukemia without maturation itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a Platelet-Boosting drug speed recovery for older leukemia patients?
Disease control CompletedThis phase II trial investigates whether eltrombopag, a drug that stimulates platelet production, can help older adults with acute myeloid leukemia (AML) recover their platelet counts faster after initial chemotherapy. Older patients often experience slow platelet recovery, which…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a targeted drug keep AML in check?
Disease control CompletedThis phase III trial tests whether the drug tipifarnib can prevent acute myeloid leukemia (AML) from coming back in patients who are already in remission. Participants include adults over 60 in first remission, those in second or later remission, or those who achieved remission a…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC